Cyclosporine A: Impact on mitochondrial function in endothelial cells

Clinical Transplantation

Volumn 25, Issue 4, 2011, Pages 584-593

  Illsinger, Sabine ^a   Janzen, Nils ^a,b   Lücke, Thomas ^a,c   Bednarczyk, Jolanthe ^a   Schmidt, Karl Heinz ^a   Hoy, Ludwig ^a   Sander, Johannes ^b   Das, Anibh M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Screening Laboratory   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cyclosporine A; Energy charge; Fatty acid oxidation; Glycolytic enzymes; Lactate; Mitochondrion; Pyruvate; Respiratory chain

Indexed keywords

6 PHOSPHOFRUCTOKINASE; CITRATE SYNTHASE; CYCLOSPORIN A; HEXOKINASE; LACTATE DEHYDROGENASE; LACTIC ACID; PHOSPHATE; PYRUVIC ACID;

ARTICLE; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FATTY ACID OXIDATION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL;

CELLS, CULTURED; CYCLOSPORINE; ELECTRON TRANSPORT; ENERGY METABOLISM; FATTY ACIDS; GLYCOLYSIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION;

EID: 80051697675     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01301.x     Document Type: Article

References (72)

1. Goldstein DJ, Zuech N, Sehgal V, Weinberg AD, Drusin R, Cohen D. Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression. Transplantation 1997: 63: 664.
2. Sanchez V, Delgado JF, Morales JM et al. Chronic cyclosporine-induced nephrotoxiciy in heart transplant patients: long-term benefits of treatment with mycophenolate mofetil and low-dose cyclosporine. Transplant Proc 2004: 36: 2823.
3. Banijamali HS, Ter Keurs MH, Ter Keurs HE, Benediktsson H, Paul LC. Effect of misoprostol on myocardial contractility in rats treated with cyclosporin A. J Cardiovasc Pharmacol 1998: 32: 139.
4. Fernandez-Sola J, Campistol J, Casademont J, Grau JM, Urbano-Marquez A. Reversible cyclosporin myopathy. Lancet 1990: 335: 362.
5. Biring MS, Fournier M, Ross DJ, Lewis MI. Cellular adaptations of skeletal muscles to cyclosporine. J Appl Physiol 1998: 84: 1967.
6. Reis F, Parada B, Teixeira de Lemos E et al. Hypertension induced by immunosuppressive drugs: a comparative analysis between sirolimus and cyclosporine. Transplant Proc 2009: 41: 868.
7. Kou R, Greif D, Michel T. Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem 2002: 277: 29669.
8. Kaya H, Koc A, Sogut S et al. The protective effect of N-acetylcysteine against cyclosporine A-induced hepatotoxicity in rats. J Appl Toxicol 2008: 28: 15.
9. Serkova NJ, Christians U, Benet LZ. Biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv 2004: 4: 97.
10. Luan FL, Zhang H, Schaubel DE et al. Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period. Am J Transplant 2008: 8: 1871.
11. Erol I, Alehan F, Ozcay F, Canan O, Haberal M. Neurological complications of liver transplantation in pediatric patients: a single center experience. Pediatr Transplant 2007: 11: 152.
12. Ishikura K, Ikeda M, Hamasaki Y et al. Posterior reversible encephalopathy syndrome in children: its high prevalence and more extensive imaging findings. Am J Kidney Dis 2006: 48: 231.
13. Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 2000: 69: 467.
14. Serkova N, Jacobsen W, Niemann CU et al. Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain. Br J Pharmacol 2001: 133: 875.
15. Hokanson JF, Mercier JG, Brooks GA. Cyclosporine A decreases rat skeletal muscle mitochondrial respiration in vitro. Am J Respir Crit Care Med 1995: 151: 1848.
16. Mercier JG, Hokanson JF, Brooks GA. Effects of cyclosporine A on skeletal muscle mitochondrial respiration and endurance time in rats. Am J Respir Crit Care Med 1995: 151: 1532.
17. Tran TT, Dai W, Sarkar HK. Cyclosporin A inhibits creatine uptake by altering surface expression of the creatine transporter. J Biol Chem 2000: 275: 35708.
18. Lemmi CA, Miller RL, Rajfer J. Inhibition of fatty acid-supported mitochondrial respiration by cyclosporine. Biochem Med Metab Biol 1990: 44: 266.
19. Lemmi CA, Pelikan PC, Geesaman B, Seamon E, Koyle M, Rajfer J. Kinetics of cyclosporine A-induced inhibition of succinate-coenzyme Q dehydrogenase in rat renal cortical mitochondria. Biochem Med Metab Biol 1990: 43: 214.
20. Serkova N, Klawitter J, Niemann CU. Organ-specific response to inhibition of mitochondrial metabolism by cyclosporine in the rat. Transpl Int 2003: 16: 748.
21. Fournier N, Ducet G, Crevat A. Action of cyclosporine on mitochondrial calcium fluxes. J Bioenerg Biomembr 1987: 19: 297.
22. Oflaz H, Turkmen A, Kazancioglu R et al. The effect of calcineurin inhibitors on endothelial function in renal transplant recipients. Clin Transplant 2003: 17: 212.
23. Ramzy D, Rao V, Tumiati LC et al. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine. Circulation 2006: 114: I214.
24. Ulrich-Merzenich G, Metzner C, Bhonde RR, Malsch G, Schiermeyer B, Vetter H. Simultaneous isolation of endothelial and smooth muscle cells from human umbilical artery or vein and their growth response to low-density lipoproteins. In Vitro Cell Dev Biol Anim 2002: 38: 265.
25. Illsinger S, Janzen N, Sander S et al. Preeclampsia and HELLP-syndrome: impaired mitochondrial function in umbilical endothelial cells. Reprod Sci 2010: 17: 219.
26. Wanders RJ, Van Roermund CW, Van Wijland MJ et al. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders. Clin Chim Acta 1987: 166: 255.
27. Wanders RJ, Van Roermund CW, Van Wijland MJ et al. Studies on the peroxisomal oxidation of palmitate and lignocerate in rat liver. Biochim Biophys Acta 1987: 919: 21.
28. Wanders RJ, Denis S, Ruiter JP, Schutgens RB, Van Roermund CW, Jacobs BS. Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts. J Inherit Metab Dis 1995: 18(Suppl 1): 113.
29. Ventura FV, Costa CG, Struys EA et al. Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects. Clin Chim Acta 1999: 281: 1.
30. Chace DH, Hillman SL, Van Hove JL, Naylor EW. Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. Clin Chem 1997: 43: 2106.
31. Rashed MS, Bucknall MP, Little D et al. Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles. Clin Chem 1997: 43: 1129.
32. Slama A, Brivet M, Boutron A, Legrand A, Saudubray JM, Demaugre F. Complementation analysis of carnitine palmitoyltransferase I and II defects. Pediatr Res 1996: 40: 542.
33. Ouhabi R, Boue-Grabot M, Mazat JP. Mitochondrial ATP synthesis in permeabilized cells: assessment of the ATP/O values in situ. Anal Biochem 1998: 263: 169.
34. Ronner P, Friel E, Czerniawski K, Frankle S. Luminometric assays of ATP, phosphocreatine, and creatine for estimation of free ADP and free AMP. Anal Biochem 1999: 275: 208.
35. Harris DA. Spectrophotometric assays. In: Harris DA, Bashford CL eds. Spectrophotometry and Spectrofluorometry. Oxford: IRL Press, 1988: 74.
36. Fischer JC, Ruitenbeek W, Trijbels JM et al. Estimation of NADH oxidation in human skeletal muscle mitochondria. Clin Chim Acta 1986: 155: 263.
37. Stumpf DA, Parks JK. Human mitochondrial electron transport chain: assay of succinate: cytochrome c reductase in leukocytes, platelets and cultured fibroblasts. Biochem Med 1981: 25: 234.
38. Wharton DC, Tzagoloff A. Cytochrome oxidase from beef heart mitochondria. Methods Enzymol 1967: 10: 6.
39. Das AM. Regulation of the mitochondrial ATP-synthase in health and disease. Mol Genet Metab 2003: 79: 71.
40. Das AM, Byrd DJ. Regulation of the mitochondrial ATP-synthase in skeletal muscle from children - a new diagnostic tool. J Inherit Metab Dis 1996: 19: 137.
41. Das AM, Byrd DJ, Brodehl J. Regulation of the mitochondrial ATP-synthase in human fibroblasts. Clin Chim Acta 1994: 231: 61.
42. Das AM, Ullrich K. Dysregulation of the mitochondrial ATP-synthase in respiratory chain defects: first experience. J Inherit Metab Dis 1998: 21: 220.
43. Rosing J, Harris DA, Kemp A Jr, Slater EC. Nucleotide-binding properties of native and cold-treated mitochondrial ATPase. Biochim Biophys Acta 1975: 376: 13.
44. Srere PA. Citrate synthase. EC 4.1.3.7. Citrate Oxaloacetate-lyase (Coa-Acetylating). In: Colowich SP, Kaplan NO eds. Methods enzymology. New York: Academic Press, 1969: 13: 3.
45. Bergmeyer HU. Methods of Enzymatic Analysis. Weinheim: Verlag Chemie; Deerfield Beach, Florida; Basel, 1983: 185.
46. Hohorst HJ. L-(+)-Lactat. In: Bergmeyer HU ed. Methoden der enzymatischen Analyse. Weinheim: Verlag Chemie, 1970: 1425.
47. Bensadoun A, Weinstein D. Assay of proteins in the presence of interfering materials. Anal Biochem 1976: 70: 241.
48. Atkinson DE. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 1968: 7: 4030.
49. Ventura FV, Ruiter JP, Ijlst L, De Almeida IT, Wanders RJ. Inhibitory effect of 3-hydroxyacyl-CoAs and other long-chain fatty acid beta-oxidation intermediates on mitochondrial oxidative phosphorylation. J Inherit Metab Dis 1996: 19: 161.
50. Harris RA, Farmer B, Ozawa T. Inhibition of the mitochondrial adenine nucleotide transport system by oleyl CoA. Arch Biochem Biophys 1972: 150: 199.
51. Morel F, Lauquin G, Lunardi J, Duszynski J, Vignais PV. An appraisal of the functional significance of the inhibitory effect of long chain acyl-CoAs on mitochondrial transports. FEBS Lett 1974: 39: 133.
52. Wojtczak L, Schonfeld P. Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acta 1993: 1183: 41.
53. Ter Veld F, Primassin S, Hoffmann L, Mayatepek E, Spiekerkoetter U. Corresponding increase in long-chain acyl-CoA and acylcarnitine after exercise in muscle from VLCAD mice. J Lipid Res 2009: 50: 1556.
54. Jung K, Pergande M. Influence of cyclosporin A on the respiration of isolated rat kidney mitochondria. FEBS Lett 1985: 183: 167.
55. Han SY, Mun KC, Choi HJ et al. Effects of cyclosporine and tacrolimus on the oxidative stress in cultured mesangial cells. Transplant Proc 2006: 38: 2240.
56. Kurus M, Esrefoglu M, Karabulut AB, Sogutlu G, Kaya M, Otlu A. Oral L-arginine protects against cyclosporine-induced hepatotoxicity in rats. Exp Toxicol Pathol 2008: 60: 411.
57. Wolf A, Trendelenburg CF, Diez-Fernandez C et al. Cyclosporine A-induced oxidative stress in rat hepatocytes. J Pharmacol Exp Ther 1997: 280: 1328.
58. Duru M, Nacar A, Yonden Z et al. Protective effects of N-acetylcysteine on cyclosporine-A-induced nephrotoxicity. Ren Fail 2008: 30: 453.
59. Christians U, Gottschalk S, Miljus J et al. Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors. Br J Pharmacol 2004: 143: 388.
60. Sahach VF, Vavilova HL, Rudyk OV, Dobrovol's'kyi FV, Shymans'ka TV, Miedviediev OS. Inhibition of mitochondrial permeability transition pore is one of the mechanisms of cardioprotective effect of coenzyme Q10. Fiziol Zh 2007: 53: 35.
61. Nicolli A, Basso E, Petronilli V, Wenger RM, Bernardi P. Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, and cyclosporin A-sensitive channel. J Biol Chem 1996: 271: 2185.
62. Fontaine E, Ichas F, Bernardi P. A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J Biol Chem 1998: 273: 25734.
63. Zorov DB, Juhaszova M, Yaniv Y, Nuss HB, Wang S, Sollott SJ. Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovasc Res 2009: 83: 213.
64. Yang L, Yang XC, Yang JK et al. Cyclosporin A suppresses proliferation of endothelial progenitor cells: involvement of nitric oxide synthase inhibition. Intern Med 2008: 47: 1457.
65. Kurus M, Esrefoglu M, Bay A, Ozturk F. Protective effect of oral L-arginine supplementation on cyclosporine induced nephropathy in rats. Int Urol Nephrol 2005: 37: 587.
66. Esposito C, Grosjean F, Torreggiani M et al. Increased asymmetric dimethylarginine serum levels are associated with acute rejection in kidney transplant recipients. Transplant Proc 2009: 41: 1570.
67. Scarpulla RC. Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator. Ann N Y Acad Sci 2008: 1147: 321.
68. Garcia-Roves PM, Huss J, Holloszy JO. Role of calcineurin in exercise-induced mitochondrial biogenesis. Am J Physiol Endocrinol Metab 2006: 290: E1172.
69. Minnich A, Tian N, Byan L, Bilder G. A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle. Am J Physiol Endocrinol Metab 2001: 280: E270.
70. Djouadi F, Aubey F, Schlemmer D et al. Potential of fibrates in the treatment of fatty acid oxidation disorders: revival of classical drugs? J Inherit Metab Dis 2006: 29: 341.
71. Davidson SM, Duchen MR. Endothelial mitochondria: contributing to vascular function and disease. Circ Res 2007: 100: 1128.
72. Suwa M, Nakano H, Kumagai S. Inhibition of calcineurin increases monocarboxylate transporters 1 and 4 protein and glycolytic enzyme activities in rat soleus muscle. Clin Exp Pharmacol Physiol 2005: 32: 218.